These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35418757)

  • 1. The Silencing of LncRNA-H19 Decreases Chemoresistance of Human Glioma Cells to Temozolomide by Suppressing Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Pathway [Retraction].
    Onco Targets Ther; 2022; 15():329-330. PubMed ID: 35418757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/β-Catenin pathway.
    Jia L; Tian Y; Chen Y; Zhang G
    Onco Targets Ther; 2018; 11():313-321. PubMed ID: 29391808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated RACK1 Attenuates Gastric Cancer Cell Growth and Epithelial-Mesenchymal Transition via Suppressing Wnt/β-Catenin Signaling [Retraction].
    Onco Targets Ther; 2022; 15():585-586. PubMed ID: 35620566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction: Emodin Inhibits Colon Cancer Cell Invasion and Migration by Suppressing Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Pathway.
    Oncology Research Editorial Office
    Oncol Res; 2024; 32(8):1375. PubMed ID: 39055898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
    Xia S; Ji R; Zhan W
    BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-188-5p Promotes Epithelial-Mesenchymal Transition by Targeting ID4 Through Wnt/β-Catenin Signaling in Retinoblastoma [Retraction].
    Onco Targets Ther; 2023; 16():841-842. PubMed ID: 37881683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA H19 regulates the development of gliomas through the Wnt/β-catenin signaling pathway.
    Guan N; Wang R; Guo WS; Lai YJ; Zhang YD; Cheng YY
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4243-4253. PubMed ID: 31173296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
    Lei T; Zhu X; Zhu K; Jia F; Li S
    Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy.
    Tomar VS; Patil V; Somasundaram K
    Cell Biol Toxicol; 2020 Jun; 36(3):273-278. PubMed ID: 31758290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retraction: RORα Suppresses Epithelial-to-Mesenchymal Transition and Invasion in Human Gastric Cancer Cells via the Wnt/β-Catenin Pathway.
    Frontiers Editorial Office
    Front Oncol; 2020; 10():607586. PubMed ID: 33194774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway [Retraction].
    Onco Targets Ther; 2023; 16():281-282. PubMed ID: 37113686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA H19 Promotes Cell Proliferation, Migration, and Angiogenesis of Glioma by Regulating Wnt5a/β-Catenin Pathway via Targeting miR-342.
    Zhou Q; Liu ZZ; Wu H; Kuang WL
    Cell Mol Neurobiol; 2022 May; 42(4):1065-1077. PubMed ID: 33161527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WISP1 silencing confers protection against epithelial-mesenchymal transition of renal tubular epithelial cells in rats via inactivation of the wnt/β-catenin signaling pathway in uremia.
    Chen YZ; Sun DQ; Zheng Y; Zheng GK; Chen RQ; Lin M; Huang LF; Huang C; Song D; Wu BQ
    J Cell Physiol; 2019 Jun; 234(6):9673-9686. PubMed ID: 30556898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA H19 promotes the osteogenic differentiation of rat ectomesenchymal stem cells via Wnt/β-catenin signaling pathway.
    Gong YY; Peng MY; Yin DQ; Yang YF
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8805-8813. PubMed ID: 30575922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronin 3 Promotes the Development of Oncogenic Properties in Glioma Through the Wnt/β-Catenin Signaling Pathway [Retraction].
    Onco Targets Ther; 2024; 17():145-146. PubMed ID: 38414760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nuclear transporter importin-11 regulates the Wnt/β-catenin pathway and acts as a tumor promoter in glioma.
    Ni H; Ji D; Li J; Zhao Z; Zuo J
    Int J Biol Macromol; 2021 Apr; 176():145-156. PubMed ID: 33571591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z; Wei X; Shen L; Zhu H; Zheng X
    Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retraction: MiR-543 Inhibits the Migration and Epithelial-To-Mesenchymal Transition of TGF-β-Treated Endometrial Stromal Cells via the MAPK and Wnt/β-Catenin Signaling Pathways.
    Pathology and Oncology Research Editorial Office
    Pathol Oncol Res; 2023; 29():1611110. PubMed ID: 37303850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV suppresses transforming growth factor-β1-induced epithelial-mesenchymal transition through inhibition of Wnt/β-catenin pathway in glioma U251 cells.
    Han J; Shen X; Zhang Y; Wang S; Zhou L
    Biosci Biotechnol Biochem; 2020 Jul; 84(7):1345-1352. PubMed ID: 32154763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin promotes bone marrow mesenchymal stem cell proliferation and osteogenic differentiation through the H19/miR-625-5p axis to activate the Wnt/β-catenin pathway.
    Bian W; Xiao S; Yang L; Chen J; Deng S
    BMC Complement Med Ther; 2021 Sep; 21(1):243. PubMed ID: 34592982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.